Our work on atrophic remodeling of the heart has caused us to appreciate a simple principle in biology: From the cell cycle to the Krebs cycle there is no life without cycles. While the potential for cellular regeneration receives much attention, the dynamics of intracellular protein turnover have received only selective consideration. Although the concept of the "dynamic state of body constituents" exists since the 1940s, the idea that heart muscle cells renew themselves from within is relatively new. For the last 30 years we (and many others) have elucidated the interaction of metabolic pathways for energy provision and contraction of the heart. Work in the field has uncovered novel metabolic regulators of enzyme action, yet the impact of myocardial energy metabolism on myocardial protein turnover has never been considered. We now propose that metabolic signals are putative regulators of myocardial protein synthesis and degradation. In a broad sense, we seek to establish mechanisms underlying the self-renewal of intact cardiomyocytes. The rationale is based on our observation that atrophic remodeling of the heart simultaneously activates pathways of intracellular protein synthesis and degradation.
Specific Aim 1 will determine how metabolic signals regulate protein degradation. It will test the hypothesis that there is a direct link between intermediary metabolism and protein degradation and that the specific molecular mechanisms involve AMPK regulation of ubiquitin ligases.
Specific Aim 2 will identify metabolic signals of protein synthesis. It will test the hypothesis that a direct link also exists between intermediary metabolism and protein synthesis, that carbohydrates regulate mTOR, and that the specific molecular mechanisms involve G6P regulation of TSC2.
Specific Aim 3 will determine how nutrient stress affects metabolic signals and protein turnover.
This aim will test the hypothesis that impaired glucose uptake (IGU) affects protein turnover when nutrients are over abundant, and that IGU protects the heart from allostatic metabolic stress in response to pressure overload. Collectively, the proposed work seeks to identify metabolic signals as regulators of myocardial protein turnover and seeks to broaden the role energy substrate metabolism from a provider of ATP to a regulator of self-renewal of the cardiomyocyte.

Public Health Relevance

The rhythmic pump action of the heart is supported by an integrated system of metabolic energy transfer. Heart cells are, in turn, made up of a large number of different proteins, all of which are continuously degraded and re-made. This self-renewal of the heart muscle cell is a highly regulated, dynamic process. It allows the heart to adapt to a wide range of changes in its environment. We have preliminary evidence to suggest that intermediary metabolites regulate pathways of both protein synthesis and degradation and are, as a consequence, regulators for the self-renewal of the heart. We are now setting out to solidify this evidence. Furthermore, we predict that identifying key metabolic regulators of intracellular protein turnover in the cardiac myocyte will increase our understanding of insulin resistance as a cardioprotective mechanism. Specifically, it is our hypothesis that insulin resistance protects the heart from overstimulation of protein synthesis and enhances cell survival of the stressed heart.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01HL061483-13
Application #
8666787
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Adhikari, Bishow B
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Bux, Ahmed S; Lindsey, Merry L; Vasquez, Hernan G et al. (2016) Glucose Regulates the Intrinsic Inflammatory Response of the Heart to Surgically Induced Hypothermic Ischemic Arrest and Reperfusion. Physiol Genomics :physiolgenomics.00102.2016
Karlstaedt, Anja; Zhang, Xiaotian; Vitrac, Heidi et al. (2016) Oncometabolite d-2-hydroxyglutarate impairs α-ketoglutarate dehydrogenase and contractile function in rodent heart. Proc Natl Acad Sci U S A 113:10436-41
Karlstaedt, Anja; Taegtmeyer, Heinrich (2016) Letter by Karlstaedt and Taegtmeyer Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy". Circ Res 119:e28
Taegtmeyer, Heinrich (2016) Failing Heart and Starving Brain: Ketone Bodies to the Rescue. Circulation 134:265-6
Rees, Meredith L; Subramaniam, Janani; Li, Yuanteng et al. (2015) A PKM2 signature in the failing heart. Biochem Biophys Res Commun 459:430-6
Wu, San-Pin; Kao, Chung-Yang; Wang, Leiming et al. (2015) Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failure. Nat Commun 6:8245
Frazier, O H; Baldwin, Andrew C W; Demirozu, Zumrut T et al. (2015) Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant 34:766-72
Kundu, Bijoy K; Zhong, Min; Sen, Shiraj et al. (2015) Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis. Cardiology 130:211-20
Harmancey, Romain; Haight, Derek L; Watts, Kayla A et al. (2015) Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart. J Biol Chem 290:30947-61
Riggs, Kayla; Ali, Hiba; Taegtmeyer, Heinrich et al. (2015) The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure. Metab Syndr Relat Disord 13:292-7

Showing the most recent 10 out of 87 publications